Company: TVRD
Filing Date: 2025-02-14
Form Type: 424B3
Source: 0001104659-25-014310
Chunk: 311

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: 424B3
Chunk 311
---
 |        |   | ​ | ​ | January 2025 |   |        |   | ​ | ​ | February 2025 |   |        |   | ​ | ​ | March 2025(1) |   |        |   | ​ |
|:---------------|:--|:--|:--------------|:--|-------:|:--|:--|:--|:--------------|:--|-------:|:--|:--|:--|:-------------|:--|-------:|:--|:--|:--|:--------------|:--|-------:|:--|:--|:--|:--------------|:--|-------:|:--|:--|
| Beginning cash | ​ | ​ | ​             | $ | 41,300 | ​ | ​ | ​ | ​             | $ | 39,459 | ​ | ​ | ​ | ​            | $ | 36,471 | ​ | ​ | ​ | ​             | $ | 34,396 | ​ | ​ | ​ | ​             | $ | 31,605 | ​ | ​ |
| Expenses       | ​ | ​ | ​             | $ |  1,841 | ​ | ​ | ​ | ​             | $ |  2,987 | ​ | ​ | ​ | ​            | $ |  2,075 | ​ | ​ | ​ | ​             | $ |  2,791 | ​ | ​ | ​ | ​             | $ |  8,422 | ​ | ​ |
| Ending cash    | ​ | ​ | ​             | $ | 39,459 | ​ | ​ | ​ | ​             | $ | 36,471 | ​ | ​ | ​ | ​            | $ | 34,396 | ​ | ​ | ​ | ​             | $ | 31,605 | ​ | ​ | ​ | ​             | $ | 23,183 | ​ | ​ |

(1) Assumed a closing date of the Merger of March 31, 2025. Interests of the Cara Directors and Executive Officers in the Merger In considering the recommendation of the Cara Board with respect to the approval of the Merger Agreement, the Merger and the issuance of shares of Cara common stock as contemplated by the Merger Agreement, and the Cara Stockholder Matters, Cara’s stockholders should be aware that certain members of the Cara Board and current